40
Participants
Start Date
October 10, 2008
Primary Completion Date
December 31, 2019
Study Completion Date
December 31, 2019
Cetuximab
Cetuximab will be given at 400mg/m\^2 IV over 120 minutes for its initial loading dose on day 1 of the first of four 21 day cycles. It will then be administered on a weekly basis at 250 mg/m\^2 IV over 60 minutes.
Ixabepilone
Ixabepilone will be given at 40mg/m\^2 IV over 180 minutes on day 1 of each of four 21 day cycles.
The Methodist Hospital Cancer Center, Houston
Collaborators (1)
Bristol-Myers Squibb
INDUSTRY
The Methodist Hospital Research Institute
OTHER